-
1
5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas
Published 2024-12-01Subjects: Get full text
Article -
2
Awardee Summary of 2023 Taiwan Oncology Society Clinical Research Award Recipient: Persistent Endeavors on Research of Digestive Cancers for Three Decades
Published 2024-01-01Subjects: “…high-dose 5-fluorouracil (5-fu) and leucovorin…”
Get full text
Article